Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 460,094 | 933,234 | 82,447 | 69,028 | 43,342 |
| Marketable Securities | 684,579 | 227,921 | 237,203 | 139,522 | 76,621 |
| Receivables | 19,936 | 12,906 | 16,837 | 11,806 | 11,346 |
| Inventories | 17,985 | 16,268 | 14,230 | 15,940 | 16,768 |
| TOTAL | $1,189,136 | $1,195,952 | $355,587 | $239,508 | $150,939 |
| Non-Current Assets | |||||
| PPE Net | 25,000 | 24,207 | 24,899 | 26,568 | 27,733 |
| Other Non-Current Assets | 31,645 | 32,729 | 33,494 | 34,242 | 34,976 |
| TOTAL | $56,645 | $56,936 | $58,393 | $60,810 | $62,709 |
| Total Assets | $1,245,781 | $1,252,888 | $413,980 | $300,318 | $213,648 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,761 | 3,471 | 3,579 | 5,406 | 7,436 |
| Accrued Expenses | 22,907 | 14,672 | 17,350 | 15,079 | 12,203 |
| Other current liabilities | 3,587 | 1,539 | 4,519 | 584 | 2,188 |
| TOTAL | $45,433 | $33,737 | $38,502 | $130,268 | $130,862 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 9,534 | 9,607 | 8,722 | 104,982 | 104,932 |
| Other Non-Current Liabilities | 931,945 | 932,911 | 38,419 | 38,793 | 39,863 |
| TOTAL | $942,103 | $938,598 | $39,987 | $40,554 | $41,394 |
| Total Liabilities | $987,536 | $972,335 | $78,489 | $170,822 | $172,256 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 198,999 | 198,373 | 193,103 | 180,213 | 154,409 |
| Common Shares | 199 | 198 | 192 | 180 | 154 |
| Retained earnings | -1,165,305 | -1,124,304 | -1,036,869 | -1,111,804 | -1,088,096 |
| Other shareholders' equity | -6 | 74 | 85 | 118 | 243 |
| TOTAL | $258,245 | $280,553 | $335,491 | $129,496 | $41,392 |
| Total Liabilities And Equity | $1,245,781 | $1,252,888 | $413,980 | $300,318 | $213,648 |